Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 11 studies | 79% ± 26% | |
enterocyte | 8 studies | 75% ± 22% | |
epithelial cell | 7 studies | 63% ± 23% | |
enteroendocrine cell | 6 studies | 57% ± 30% | |
intestinal crypt stem cell | 4 studies | 86% ± 14% | |
transit amplifying cell | 4 studies | 91% ± 13% | |
progenitor cell | 4 studies | 78% ± 35% | |
brush cell | 3 studies | 67% ± 7% | |
pancreatic ductal cell | 3 studies | 47% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 8 studies | 48% ± 30% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 50651.93 | 961 / 966 | 96% | 1409.36 | 506 / 527 |
stomach | 98% | 3399.92 | 352 / 359 | 92% | 1065.34 | 264 / 286 |
pancreas | 100% | 1534.76 | 328 / 328 | 83% | 784.92 | 147 / 178 |
liver | 100% | 3547.97 | 226 / 226 | 73% | 459.22 | 298 / 406 |
bladder | 100% | 828.95 | 21 / 21 | 31% | 418.58 | 155 / 504 |
esophagus | 76% | 110.98 | 1101 / 1445 | 46% | 340.86 | 84 / 183 |
spleen | 100% | 331.81 | 241 / 241 | 0% | 0 | 0 / 0 |
breast | 96% | 378.82 | 442 / 459 | 0% | 0 | 0 / 1118 |
lung | 77% | 104.94 | 447 / 578 | 18% | 106.74 | 213 / 1155 |
thymus | 95% | 155.59 | 622 / 653 | 0% | 0 | 0 / 605 |
ovary | 94% | 131.71 | 170 / 180 | 0% | 0.81 | 1 / 430 |
kidney | 85% | 107.31 | 76 / 89 | 9% | 36.05 | 80 / 901 |
prostate | 93% | 209.80 | 228 / 245 | 0% | 0 | 0 / 502 |
uterus | 83% | 116.00 | 141 / 170 | 6% | 30.90 | 29 / 459 |
adipose | 86% | 110.96 | 1039 / 1204 | 0% | 0 | 0 / 0 |
muscle | 70% | 72.59 | 561 / 803 | 0% | 0 | 0 / 0 |
skin | 67% | 85.41 | 1218 / 1809 | 0% | 0 | 0 / 472 |
blood vessel | 39% | 35.34 | 524 / 1335 | 0% | 0 | 0 / 0 |
heart | 39% | 33.37 | 332 / 861 | 0% | 0 | 0 / 0 |
brain | 38% | 35.47 | 1005 / 2642 | 0% | 0 | 0 / 705 |
adrenal gland | 33% | 21.88 | 86 / 258 | 0% | 0 | 0 / 230 |
peripheral blood | 30% | 46.59 | 276 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002780 | Biological process | antibacterial peptide biosynthetic process |
GO_0007155 | Biological process | cell adhesion |
GO_0005615 | Cellular component | extracellular space |
GO_0005829 | Cellular component | cytosol |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005886 | Cellular component | plasma membrane |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
GO_0016936 | Molecular function | galactoside binding |
Gene name | LGALS4 |
Protein name | Galectin 4 Galectin Galectin-4 (Gal-4) (Antigen NY-CO-27) (L-36 lactose-binding protein) (L36LBP) (Lactose-binding lectin 4) |
Synonyms | hCG_20525 |
Description | FUNCTION: Galectin that binds lactose and a related range of sugars. May be involved in the assembly of adherens junctions. |
Accessions | ENST00000307751.9 Q6FHZ4 ENST00000634573.2 P56470 ENST00000594209.1 M0R1B2 ENST00000595291.5 M0QZ93 ENST00000600070.1 M0R349 |